Inoky-Glucotest

Glucose, the active ingredient in Inoky-Glucotest, is an excipient presented as a oral formulation for oral use. It provides a readily absorbable source of carbohydrate energy and is used to address low blood‑sugar conditions and support caloric intake in various populations.

GNH USA supplies Inoky-Glucotest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare facilities worldwide, with consistent quality and regulatory compliance.

Inoky-Glucotest delivers glucose, a simple carbohydrate that supports blood‑sugar regulation and provides energy in clinical nutrition contexts.

- Hypoglycemia: rapid elevation of blood glucose to alleviate low‑sugar symptoms. - Energy supplementation: supplies readily available calories for patients with increased metabolic needs. - Oral rehydration solutions: acts as the carbohydrate component to aid fluid and electrolyte replacement.

Oral glucose is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: cramping or bloating. - Diarrhea: loose stools with excessive intake. - Hyperglycemia: elevated blood sugar in susceptible individuals. - Headache: occasional tension-type headache. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe hyperglycemia: may require medical intervention. - Allergic reaction: rash, itching, or swelling; discontinue use and seek care.

When using Inoky-Glucotest, consider the following safety measures.

- Monitor blood glucose levels: check before and after administration to avoid excessive rise. - Use cautiously in diabetic patients: may require adjustment of antidiabetic therapy. - Avoid excessive dosing: high caloric intake can lead to weight gain. - Check for hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Glucose can interact with several medications; awareness of these interactions helps maintain therapeutic balance.

Major Interactions (Avoid): - Insulin therapy: may require dose adjustment to prevent hypoglycemia. - Oral hypoglycemic agents: risk of unexpected hyperglycemia. - SGLT2 inhibitors: altered glucose handling may affect efficacy.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Corticosteroids: can increase blood glucose levels. - Thyroid hormones: may modify metabolic rate and glucose utilization.